Association of the ninth-edition pathological N2a/N2b subclassification with survival in resected non-small cell lung cancer: A systematic review and meta-analysis

The ninth edition of the TNM classification subdivides pathological N2 disease into single-station (pN2a) and multiple-station (pN2b) involvement, but the magnitude and consistency of survival differences between these subgroups after resection for non-small cell lung cancer (NSCLC) remain uncertain. PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus, and the Cochrane Library were searched for studies published from January 1, 2023, through October 6, 2026. Eligible studies compared station-defined pN2b with pN2a in adults with M0 NSCLC and pathologically confirmed N2 disease after curative-intent resection. The primary outcome was overall survival (OS); recurrence-free survival (RFS), disease-free survival (DFS), and freedom from recurrence (FFR) were secondary outcomes. Hazard ratios (HRs) were pooled using random-effects inverse-variance models. Risk of bias was assessed using the Quality In Prognosis Studies (QUIPS) tool. Ten retrospective cohorts included 3,809 patients (2,310 pN2a; 1,499 pN2b). Four studies contributed multivariable-adjusted HRs to the primary OS analysis, showing poorer OS with pN2b (HR, 1.58; 95% CI, 1.40–1.77; I² = 0%). The analysis including all eight studies yielded a similar association (HR, 1.50; 95% CI, 1.37–1.65; I² = 0%). Endpoint-specific analyses included five studies of RFS (HR, 1.49; 95% CI, 1.27–1.75), two of DFS (HR, 1.39; 95% CI, 1.16–1.66), and two of FFR (HR, 1.70; 95% CI, 1.45–1.99). Multiple-station pathological N2 involvement was associated with poorer overall survival and recurrence-related outcomes than single-station involvement after NSCLC resection. Whether this subdivision improves prognostic discrimination remains uncertain.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-21
DOI
https://doi.org/10.1186/s12885-026-17440-x
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of the ninth-edition pathological N2a/N2b subclassification with survival in resected non-small cell lung cancer: A systematic review and meta-analysis

Yingding Ruan, Jianwei Han, Wenjun Cao, Chuan Long et al.
BMC Cancer
Lung Cancer Diagnosis and Treatment
article

Association of the ninth-edition pathological N2a/N2b subclassification with survival in resected non-small cell lung cancer: A systematic review and meta-analysis

Yingding Ruan, Jianwei Han, Wenjun Cao, Chuan Long, Ting Zhang
article en

Abstract

The ninth edition of the TNM classification subdivides pathological N2 disease into single-station (pN2a) and multiple-station (pN2b) involvement, but the magnitude and consistency of survival differences between these subgroups after resection for non-small cell lung cancer (NSCLC) remain uncertain. PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus, and the Cochrane Library were searched for studies published from January 1, 2023, through October 6, 2026. Eligible studies compared station-defined pN2b with pN2a in adults with M0 NSCLC and pathologically confirmed N2 disease after curative-intent resection. The primary outcome was overall survival (OS); recurrence-free survival (RFS), disease-free survival (DFS), and freedom from recurrence (FFR) were secondary outcomes. Hazard ratios (HRs) were pooled using random-effects inverse-variance models. Risk of bias was assessed using the Quality In Prognosis Studies (QUIPS) tool. Ten retrospective cohorts included 3,809 patients (2,310 pN2a; 1,499 pN2b). Four studies contributed multivariable-adjusted HRs to the primary OS analysis, showing poorer OS with pN2b (HR, 1.58; 95% CI, 1.40–1.77; I² = 0%). The analysis including all eight studies yielded a similar association (HR, 1.50; 95% CI, 1.37–1.65; I² = 0%). Endpoint-specific analyses included five studies of RFS (HR, 1.49; 95% CI, 1.27–1.75), two of DFS (HR, 1.39; 95% CI, 1.16–1.66), and two of FFR (HR, 1.70; 95% CI, 1.45–1.99). Multiple-station pathological N2 involvement was associated with poorer overall survival and recurrence-related outcomes than single-station involvement after NSCLC resection. Whether this subdivision improves prognostic discrimination remains uncertain.

BMC Cancer
The First People's Hospital of Changde (CN), Affiliated Zhongshan Hospital of Dalian University (CN), Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon